Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Halsey

Showing results (171-180 of 178) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 178 results.
Cancer Research|January 1, 1987
Relationship between the neurotoxicity of the hypoxic cell radiosensitizer SR 2508 and the pharmacokinetic profileC N Coleman, J Halsey, R S Cox, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistanceA M Yahanda, K M Alder, G A Fisher, et al.
The Journal of Clinical Endocrinology and Metabolism|May 26, 2005
Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomyC W le Roux, N M Neary, T J Halsey, et al.
Cancer Research|June 15, 1988
Enhancement of the clinical activity of melphalan by the hypoxic cell sensitizer misonidazoleC N Coleman, R W Carlson, R A Artim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistanceB L Lum, S Kaubisch, A M Yahanda, et al.
Ecology and Evolution|January 9, 2023
"Where do I even start?" Recommendations for faculty diversifying syllabi in ecology, evolution, and the life sciencesTolulope I N Perrin-Stowe, Melissa Horner, Jaime J Coon, et al.
Allergy|October 3, 2009
National pholcodine consumption and prevalence of IgE-sensitization: a multicentre studyS G O Johansson, E Florvaag, H Oman, et al.
Science (New York, N.Y.)|February 27, 2025
Protect US racial affinity groupsV Bala Chaudhary, Sora Kim, Mónica Medina, et al.
Pageof 18

Showing results (171-180 of 178) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 178 results.
Cancer Research|January 1, 1987
Relationship between the neurotoxicity of the hypoxic cell radiosensitizer SR 2508 and the pharmacokinetic profileC N Coleman, J Halsey, R S Cox, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistanceA M Yahanda, K M Alder, G A Fisher, et al.
The Journal of Clinical Endocrinology and Metabolism|May 26, 2005
Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomyC W le Roux, N M Neary, T J Halsey, et al.
Cancer Research|June 15, 1988
Enhancement of the clinical activity of melphalan by the hypoxic cell sensitizer misonidazoleC N Coleman, R W Carlson, R A Artim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistanceB L Lum, S Kaubisch, A M Yahanda, et al.
Ecology and Evolution|January 9, 2023
"Where do I even start?" Recommendations for faculty diversifying syllabi in ecology, evolution, and the life sciencesTolulope I N Perrin-Stowe, Melissa Horner, Jaime J Coon, et al.
Allergy|October 3, 2009
National pholcodine consumption and prevalence of IgE-sensitization: a multicentre studyS G O Johansson, E Florvaag, H Oman, et al.
Science (New York, N.Y.)|February 27, 2025
Protect US racial affinity groupsV Bala Chaudhary, Sora Kim, Mónica Medina, et al.
Pageof 18